Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Simvastatin Loaded Polycaprolactone-Collagen Scaffolds for the treatment of Diabetic Foot Ulcer


Affiliations
1 Department of Pharmaceutics, JSS College of Pharmacy, Ooty, India
     

   Subscribe/Renew Journal


Scaffolds are the adaptable tools for the treatment of diabetic wounds, In this study, Simvastatin was loaded in polycaprolactone-collagen scaffolds for the treatment of diabetic foot ulcer using the freeze-drying technique. Eventually scaffolds characterization were observed in terms of Scanning Electron Microscopy, Differential scanning calorimetry (DSC), Porosity, Water absorption test, Matrix degradation, In vitro drug release studies, cell proliferation assay, cytotoxicity assay. Scaffolds prepared with polycaprolactone and collagen-polymer showed the homogeneous distribution with high porosity, extended biodegradation rate, high water uptake. All the scaffold formulation showed the sustained drug release and then a plateau. The cross-Linked scaffold has significant slower release in comparison to non-crosslinked scaffold, this is because of cross-linking of the scaffolds where the chemical and mechanical bonding is high compared to non-crosslinked scaffold, Non-crosslinked, showed 85.34% of drug release by this it can be concluded that non cross-linked scaffolds showed the prolonged release, In the cell proliferation assay after 72 h, the cell growth was found to be greater when we compared with placebo and control due to the presence of drug, which explains that the cells are in logarithmic phase. Noncross linked scaffold has shown an increase in cell growth by 28% from its initial value. In Differential Scanning Calorimetry (DSC) shows that there is no change in the peaks by that we can confirm that all the excipients are compatible to each other The obtained results imply that the investigated scaffold is a potential candidate for skin regeneration application because the present study states that simvastatin is having all the properties to treat the Diabetic Foot Ulcer(DFU) without producing the resistance.

Keywords

Simvastatin, Polycaprolactone, Collagen, Composite Scaffolds, Diabetic Wounds.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Karri VVSR, Kuppusamy G, Talluri SV, Yamjala K, Mannemala SS, Malayandi R. Current and emerging therapies in the management of diabetic foot ulcers. Curr Med Res Opin [Internet]. 2016;32(3):519–42. Available from: http://www.tandfonline.com/doi/full/10.1185/03007995.2015.1128888

  • Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861–85.

  • Mahmoud AA, Salama AH. Norfloxacin-loaded collagen/chitosan scaffolds for skin reconstruction: Preparation, evaluation and in-vivo wound healing assessment. Eur J Pharm Sci [Internet]. 2016; 83:155–65. Available from: http://dx.doi.org/10.1016/j.ejps.2015.12.026

  • Mir M, Najabat M, Afifa A, Ayesha B, Munam G, Shizza A. Synthetic polymeric biomaterials for wound healing: a review. Prog Biomater [Internet]. 2018; (Mostow 1994). Available from: https://doi.org/10.1007/s40204-018-0083-4

  • Cínthia A, Irami R, Filho A, Damasceno BPGL, Sócrates E, Egito T. Simvastatin improves the healing of infected skin wounds of rats 1 A Simvastatina melhora a cicatrização de feridas infectadas da pele de ratos. 2007;22(Supplement 1):57–63.

  • Farsaei S, Khalili H, Farboud ES. Potential role of statins on wound healing: review of the literature. 2012;238–47.

  • Baxter R, Hastings N, Law a., Glass EJ. [ No Title]. Anim Genet. 2008;39(5):561–3.

  • Thangavel P, Ramachandran B, Muthuvijayan V. Fabrication of chitosan / gallic acid 3D microporous scaffold for tissue engineering applications. 2015;750–60.

  • Sultana N, Khan TH. Water absorption and diffusion characteristics of nanohydroxyapatite (nHA) and poly(hydroxybutyrate-co-hydroxyvalerate-) based composite tissue engineering scaffolds and nonporous thin films. J Nanomater. 2013;2013.

  • Kumar PTS, Srinivasan S, Lakshmanan V, Tamura H, Nair S V, Jayakumar R. ␤ -Chitin hydrogel / nano hydroxyapatite composite scaffolds for tissue engineering applications. Carbohydr Polym [Internet]. 2011;85(3):584–91. Available from: http://dx.doi.org/10.1016/j. carbpol.2011.03.018

  • Sun X, Wang J, Wang Y, Zhang Q. Collagen-based porous scaffolds containing PLGA microspheres for controlled kartogenin release in cartilage tissue engineering. Artif Cells, Nanomedicine, Biotechnol [Internet]. 2017;0(0):1–10. Available from: https://doi.org/10.1080/21691401.2017.1397000

  • Vernon RB, Gooden MD, Lara SL, Wight TN. Microgrooved fibrillar collagen membranes as scaffolds for cell support and alignment. 2005; 26:3131–40.

  • Demirci S, Doğan A, Demirci Y, Şahin F. In vitro wound healing activity of methanol extract of Verbascum speciosum. 2014;7(3):37–44.

  • Saurabh Mehta. Review of Heterocyclic Scaffolds for the Inhibitors of ATP synthase. Asian J. Research Chem. 2018; 11(2):505-508.

  • Radhika G, Sreelakshmi Divya P, Prashanth Reddy G, Venkatesh P, Ravindra Reddy K. An Overview on Regenerative Medicine. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 727-728.

  • Hisham A. Abbas. Diabetic Foot Infection. Research J. Pharm. and Tech. 8(5): May, 2015; Page 575-579.

  • P. Maheshwari, D. Pavithra, Neethu. T. T, T.S. Shanmugarajan, P. Shanmugasundaram. Study on Health Outcomes in Diabetic Patients - Association Between Diabetic Foot Ulcer and Psychological Distress. Research J. Pharm. and Tech. 2017; 10(1): 44-48.

  • Radhika Chelamalla, Ajitha Makula. Molecular docking studies and ADMET Predictions of Pyrimidine Coumarin Scaffolds as Potential IDO Inhibitors. Asian J. Research Chem. 2017; 10(3):331-340.

  • Bonshikachatterjee, Nivetha. A, Mohanasrinivasan. V. Immobilization of β-galactosidase in Chitosan-Alginate composite scaffolds and optimization of lactose hydrolysis. Research J. Pharm. and Tech 2018; 11(4): 1480-1485.

  • Smriti Agarwal, Vinayak Jhunjhunwala, G. Priya. Fabrication and Morphological Analysis of Gelatin-Alginate Scaffolds. Research J. Pharm. and Tech 2018; 11(9): 3816-3818.

  • Saumya S, Agila Anbuselvan, Poorva S, G. Priya. A Review on 3D Printing Techniques and Scaffolds for Auricular Cartilage Reconstruction. Research J. Pharm. and Tech 2018; 11(9): 4179-4186

  • Keerthic Aswin S, Jothishwar S, Visvavela Chellaih Nayagam P, G. Priya. Scaffolds for Biomolecule Delivery and Controlled Release–A Review. Research J. Pharm. and Tech 2018; 11(10): 4719-4730.

  • Hisham A. Abbas, Mona A. El-Sayed, Laila M. Al-Kadi, Amany I. Gad. Diabetic foot infections in Zagazig University Hospital: bacterial etiology, antimicrobial resistance and biofilm formation. Research J. Pharm. and Tech. 7(7): July 2014 Page 783-788

  • P. Maheshwari, D. Pavithra, Neethu. T. T, T.S. Shanmugarajan, P. Shanmugasundaram. Study on Health Outcomes in Diabetic Patients - Association Between Diabetic Foot Ulcer and Psychological Distress. Research J. Pharm. and Tech. 2017; 10(1): 44-48.

  • Robson MC, Mustoe TA, Hunt TK. The future recombinant growth factors in wound healing. Am J Surg 1998;2(suppl 1):80-2S


Abstract Views: 262

PDF Views: 0




  • Simvastatin Loaded Polycaprolactone-Collagen Scaffolds for the treatment of Diabetic Foot Ulcer

Abstract Views: 262  |  PDF Views: 0

Authors

C. Kalaivani
Department of Pharmaceutics, JSS College of Pharmacy, Ooty, India
Gowthamarajan Kuppusamy
Department of Pharmaceutics, JSS College of Pharmacy, Ooty, India
Saikamal
Department of Pharmaceutics, JSS College of Pharmacy, Ooty, India
Veera Venkata Satyanarayana Reddy Karri
Department of Pharmaceutics, JSS College of Pharmacy, Ooty, India

Abstract


Scaffolds are the adaptable tools for the treatment of diabetic wounds, In this study, Simvastatin was loaded in polycaprolactone-collagen scaffolds for the treatment of diabetic foot ulcer using the freeze-drying technique. Eventually scaffolds characterization were observed in terms of Scanning Electron Microscopy, Differential scanning calorimetry (DSC), Porosity, Water absorption test, Matrix degradation, In vitro drug release studies, cell proliferation assay, cytotoxicity assay. Scaffolds prepared with polycaprolactone and collagen-polymer showed the homogeneous distribution with high porosity, extended biodegradation rate, high water uptake. All the scaffold formulation showed the sustained drug release and then a plateau. The cross-Linked scaffold has significant slower release in comparison to non-crosslinked scaffold, this is because of cross-linking of the scaffolds where the chemical and mechanical bonding is high compared to non-crosslinked scaffold, Non-crosslinked, showed 85.34% of drug release by this it can be concluded that non cross-linked scaffolds showed the prolonged release, In the cell proliferation assay after 72 h, the cell growth was found to be greater when we compared with placebo and control due to the presence of drug, which explains that the cells are in logarithmic phase. Noncross linked scaffold has shown an increase in cell growth by 28% from its initial value. In Differential Scanning Calorimetry (DSC) shows that there is no change in the peaks by that we can confirm that all the excipients are compatible to each other The obtained results imply that the investigated scaffold is a potential candidate for skin regeneration application because the present study states that simvastatin is having all the properties to treat the Diabetic Foot Ulcer(DFU) without producing the resistance.

Keywords


Simvastatin, Polycaprolactone, Collagen, Composite Scaffolds, Diabetic Wounds.

References